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Antibiotic Resistance Mediated by
the MacB ABC Transporter Family: A
Structural and Functional
Perspective
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1Department of Pathology, University of Cambridge, Cambridge, United Kingdom, 2 School of Life Sciences, University of
Warwick, Coventry, United Kingdom
The MacB ABC transporter forms a tripartite efflux pump with the MacA adaptor protein
and TolC outer membrane exit duct to expel antibiotics and export virulence factors
from Gram-negative bacteria. Here, we review recent structural and functional data
on MacB and its homologs. MacB has a fold that is distinct from other structurally
characterized ABC transporters and uses a unique molecular mechanism termed
mechanotransmission. Unlike other bacterial ABC transporters, MacB does not transport
substrates across the inner membrane in which it is based, but instead couples
cytoplasmic ATP hydrolysis with transmembrane conformational changes that are used
to perform work in the extra-cytoplasmic space. In the MacAB-TolC tripartite pump,
mechanotransmission drives efflux of antibiotics and export of a protein toxin from
the periplasmic space via the TolC exit duct. Homologous tripartite systems from
pathogenic bacteria similarly export protein-like signaling molecules, virulence factors
and siderophores. In addition, many MacB-like ABC transporters do not form tripartite
pumps, but instead operate in diverse cellular processes including antibiotic sensing, cell
division and lipoprotein trafficking.
Keywords: antibiotic resistance, tripartite efflux pump, MacB, mechanotransmission, ABC transporter, lantibiotic,
membrane protein, antimicrobial resistance
INTRODUCTION
ABC (ATP-binding cassette) transporters are present in all three domains of life, and mediate
transmembrane transport of a diverse array of substrates including drugs, sugars, ions, amino
acids and proteins (ter Beek et al., 2014; Locher, 2016). All ABC transporters possess conserved
nucleotide binding domains (NBDs) that facilitate power generation through ATP hydrolysis, and
transmembrane domains (TMDs) that determine transporter function. The NBDs at the core of all
ABC transporters are homologous, while the TMDs are structurally heterogeneous and proposed to
have discrete evolutionary origins (Wang et al., 2009; ter Beek et al., 2014; Locher, 2016). Analysis of
available ABC transporter crystal structures shows that there are at least seven structurally distinct
ABC transporter folds, of which MacB is the most-recently determined representative (Figure 1).
MacB is therefore the “holotype” for the Type VII ABC transporter superfamily (Crow et al., 2017),
and the first structurally-characterized member of a clade of ABC transporters classified by Saier as
the ABC3 superfamily (Wang et al., 2009).
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FIGURE 1 | Seven ABC transporter superfamilies. A single representative from each superfamily is shown colored by protein chain. PDB identifiers are given in
parentheses. The seven ABC folds are here further divided into three “classes” based on function. Families I-III are importers, Type IV and V are exporters and Types VI
and VII are mechanotransducers. Note that the two ABC exporter families here termed Type IV and Type V are also sometimes referred to as type I and II ABC
exporters. From left to right: the molybdate transporter (Hollenstein et al., 2007) (ModABC), vitamin B12 transporter (Korkhov et al., 2012) (BtuCDF), folate importer
(Xu et al., 2013) (Ecf-FolT), multidrug exporter (Dawson and Locher, 2006) (Sav1866), the sterol transporter (Lee et al., 2016) (ABCG5/G8), the lipopolysaccharide
extractor (Luo et a., 2017) (LptBFG) and the enterotoxin and macrolide transporter (Crow et al., 2017) (MacB). Folds are named by extension of a previously
established convention (ter Beek et al., 2014). Adapted from Crow et al. (2017).
ABC transporters with roles in antibiotic resistance are
typically exporters, and operate by some variation of an
alternating access mechanism (see below) (ter Beek et al.,
2014; Locher, 2016). In bacteria, ABC exporters possess six
transmembrane helices (TMHs) and operate as dimers. In
eukaryotes, they typically exist as apparent fusions of two half
transporters, that are otherwise structurally similar to their
bacterial counterparts (Locher, 2016). Key examples of ABC
exporters include Sav1866 from Staphylococcus aureus (Dawson
and Locher, 2006), Bacillus subtilis LmrA (van Veen et al., 1996)
and P-glycoprotein from humans (Aller et al., 2009).
Structures of ABC transporters in the presence and absence
of ATP reveal different conformations which led to the proposal
of an alternating access mechanism for transport (ter Beek et al.,
2014; Locher, 2016). ATP-dependent conformational changes in
the NBDs cause the TMDs to cycle between “inward open” and
“outward open” states allowing substrate to be bound at one side
of the membrane and released on the other. In the inward open
state, the NBDs are parted and substrates can bind to a site at
the interface of the TMDs, exposed to the cytoplasmic side of
themembrane (Johnson and Chen, 2017). ATP binding promotes
tight association of the NBDs and is communicated to the TMDs
through a conserved coupling helix (Dawson and Locher, 2006).
The resultant reorganization of the TMD results in an “outward-
open” state with a reduced affinity for substrate allowing release
on the distal side of the membrane (Ramachandra et al., 1998;
Johnson and Chen, 2018). ATP hydrolysis then resets the
transporter to an inward facing conformation. The stoichiometry
of ATP hydrolysis per translocation event is unclear since
heterodimeric transporters with only one functional NBD are
translocation competent (Zutz et al., 2011). Transport may be
further aided by the transmembrane proton electrochemical
gradient (Singh et al., 2016). Structures of occluded states, in
which the binding site is not accessible to either side of the
membrane, lack substrate but represent plausible intermediates
on the pathway between inward and outward open states
(Choudhury et al., 2014; Lin et al., 2015a; Bountra et al.,
2017). Variations of the mechanism in which only the outward
facing state takes part in transport have been proposed (Perez
et al., 2015; Locher, 2016). Indeed, it has been suggested
that the diverse structures and substrates of ABC transporters
are incompatible with a single unified transport mechanism
(Locher, 2016).
In Gram-positive bacteria, ABC transporters are widely used
to expel xenobiotics (Lubelski et al., 2007). Antibiotic eﬄux
by Gram-negative ABC transporters has been less well studied
although expression of Stenotrophomonas maltophila SmrA (Al-
Hamad et al., 2009) or Serratia marcescens SmdAB (Matsuo et al.,
2008), in hypersusceptible E. coli, provides resistance to multiple
drugs including norfloxacin and tetracycline. Overexpression of
E. coli MsbA confers resistance to multiple drugs in E. coli and
Lactococcus lactis (Reuter et al., 2003; Woebking et al., 2005).
Most ABC exporters operate independently to transport
substrates across the cytoplasmic membrane in which they are
embedded. However, in Gram-negative bacteria specific ABC
transporters can form part of tripartite eﬄux pumps, larger
assemblies that span the entire cell envelope and mediate
transport across the outer membrane.
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TRIPARTITE EFFLUX PUMPS (TEPs):
BACTERIAL NANOMACHINES DRIVING
ANTIBIOTIC EFFLUX
Gram-negative bacteria use tripartite eﬄux pumps that span
both inner and outer membranes to export and eﬄux noxious
molecules including antibiotics. They are a major determinant
of multidrug resistance (Hinchliffe et al., 2013). The pumps
consist of an outer membrane exit duct exemplified by E. coli
TolC (Koronakis et al., 2000), a periplasmic adaptor protein
and an inner membrane transporter. The periplasmic adaptors
have a conserved, multi-domain, architecture consisting of
membrane proximal (MP), β-barrel, lipoyl and hairpin domains,
although some adaptors lack one of these domains (Greene
et al., 2013; Hinchliffe et al., 2014). The energy-transducing
inner membrane transporter comes from one of four distinct
classes. The Resistance-Nodulation-Cell Division (RND) e.g.,
AcrB and Major Facilitator Superfamily (MFS) transporters e.g.,
EmrB both couple export to dissipation of the transmembrane
electrochemical ion gradient. Conversely, ATP hydrolysis is used
by two distinct ABC transporters, HlyB and MacB, that account
for the third and fourth TEP types (Figure 2). In E. coli, all
four TEP classes use one outer membrane eﬄux protein, TolC
(Hinchliffe et al., 2013).
The Different Classes of Transporter
Powering TEPs
Structures of the best characterized RND inner membrane
component, AcrB, were first determined over 15 years ago. AcrB
functions as a homotrimer, with each monomer containing 12
TMHs and an extensive periplasmic domain projecting 70 Å into
the periplasm (Murakami et al., 2002). Subsequent structures
revealed asymmetric AcrB trimers in which individual AcrB
monomers adopted different conformational states (Murakami
et al., 2006; Seeger et al., 2006). This led to the proposal of a
transport mechanism in which each monomer cycles between
open, loose and tight substrate-binding states to effect transport.
The broad substrate specificity of AcrB is explained by multiple
binding sites for drugs and entry routes from both the outer
leaflet of the inner membrane and the periplasm (Nakashima
et al., 2011; Eicher et al., 2012; Zwama et al., 2018). More
recently, structures of the assembled AcrAB-TolC complex have
been obtained using negative-stain and cryo-electronmicroscopy
(cryo-EM) (Du et al., 2014; Daury et al., 2016; Wang et al., 2017).
MFS transporters associating with TEPs have been less
well studied. In E. coli, the exemplar is EmrB which, with
its cognate adaptor EmrA, confers resistance to hydrophobic
compounds including the proton-motive force uncoupler, CCCP,
and nalidixic acid (Lomovskaya and Lewis, 1992). EmrB is
predicted to have 14 TMHs and, unlike other TEP transporters,
lacks a substantial periplasmic domain (Tanabe et al., 2009).
Consistent with this, EmrA does not have an MP domain
(Hinchliffe et al., 2014) that in other transporters forms extensive
interactions with the transporter periplasmic domain (Du et al.,
2014). MFS transporters have been reported to operate either as
monomers or dimers (Quistgaard et al., 2016). Purified EmrB
was reported to form dimers (Tanabe et al., 2009) whereas
the diameter of a modeled EmrA hexamer was compatible
with monomeric EmrB (Hinchliffe et al., 2014). Further
studies are required to understand the EmrB stoichiometry
in vivo and the EmrA-EmrB interactions underpinning pump
assembly.
In E. coli, two very different ABC transporters form TolC-
dependent TEPs; HlyB and MacB. HlyB acts in concert with
the adaptor HlyD to export the large protein toxin, hemolysin
FIGURE 2 | Four classes of Tripartite Efflux Pump. From left to right, Resistance-Nodulation-Cell Division (RND) family pump, AcrAB-TolC; Major Facilitator
Superfamily (MFS) pump, EmrAB-TolC; Type I secretion system (T1SS), HlyBD-TolC; MacB superfamily pump, MacAB-TolC. IM and OM indicate the inner and outer
membranes respectively.
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A (HlyA), from the cytoplasm across both membranes in a
concerted step (Thanabalu et al., 1998). Topological analysis,
and the crystal structure of a peptide exporting homolog
(PCAT1), demonstrate HlyB has a classic 6-TMH topology
with the NBD fused to the C-terminus (Lin et al., 2015a).
Conversely, sequence analysis of E. coli MacB suggested that
it has an atypical topology. An N-terminal cytoplasmic NBD
is followed by four TMHs, with a large periplasmic domain
of approximately 200 amino acids situated between TMH1
and TMH2. The 4-TMH topology predicted from amino
acid sequence was experimentally confirmed by site-specific
chemical modification of single cysteine residues (Kobayashi
et al., 2003). Subsequent bioinformatic analysis revealed the
MacB architecture is widespread throughout bacterial genomes
(Khwaja et al., 2005; Wang et al., 2009).
The MacAB-TolC TEP Mediates Antibiotic
Resistance and Export of Virulence Factors
MacB, along with its periplasmic adaptor protein MacA, was first
identified in a screen of E. coli transporter genes as providing
resistance to macrolide drugs in a strain lacking the major
RND eﬄux pump AcrAB (Kobayashi et al., 2001). Further
studies demonstrated that expression of MacAB increases
E. coli resistance to colistin and bacitracin (Crow et al., 2017).
Additionally, the MacAB-TolC TEP supports the export of small
proteins such as enterotoxin STII (Yamanaka et al., 2008), and is
suggested to export the heme-precursor protoporphyrin (Turlin
et al., 2014).
The role of the MacAB-TolC TEP has been investigated
in other Gram-negative species. S. maltophila MacAB confers
resistance to a variety of macrolides, aminoglycosides and
polymyxins (Lin et al., 2014). InNeisseria gonorrhoeae,mutations
in the macAB promoter increase macrolide resistance in a
strain lacking the RND pump MtrCDE (Rouquette-Loughlin
et al., 2005). Acinetobacter baumannii MacAB expression is
significantly upregulated in both multidrug-resistant clinical
strains (Lin et al., 2015b), and colistin-resistant strains devoid
of LPS (Henry et al., 2012). Expression of the Vibrio cholerae
MacAB homolog VarDEF increases resistance to four different
macrolides by 8-fold or greater (Lin et al., 2017), and these
genes were upregulated in presence of polymyxin B (Matson
et al., 2017). In Pseudomonas species, homologs of MacB secrete
toxins (Balibar et al., 2005; Dubern et al., 2008; Lim et al.,
2009; Cho and Kang, 2012; Li et al., 2013), and siderophores
such as pyoverdine (Imperi et al., 2009; Hannauer et al.,
2010). Deletion of MacB impacts virulence of Salmonella in
a mouse model (Nishino et al., 2006), possibly by promoting
survival within macrophages (Bogomolnaya et al., 2013). Taken
together, MacB, in concert with the adaptor MacA and the
outer membrane exit duct, TolC, can underpin eﬄux of a
variety of drugs and export of virulence factors from multiple
Gram-negative bacterial species. While TolC expression is
constitutive, expression of MacAB in Salmonella and E. coli
is regulated by the PhoPQ two-component system (Nishino
et al., 2006). Among other stimuli, PhoPQ senses and responds
to host antimicrobial peptides and peptide antibiotics (Bader
et al., 2005; Prost et al., 2007). Thus, MacAB production
is likely to be induced in response to challenge with these
agents.
STRUCTURAL BIOLOGY OF THE
MacAB-TolC SYSTEM
Studies by the Zgurskaya lab demonstrate that the ATPase
activity of reconstituted MacB is dependent on intact MacA.
Furthermore, MacAB mediated antibiotic resistance in vivo
requires the presence of the outer membrane eﬄux channel TolC
(Tikhonova et al., 2007). Taken together, these data confirm
that MacAB-TolC forms a functional TEP. Recently, crystal
structures of the individual components, and a cryo-EM structure
of the entire pump, have been elucidated, providing substantive
insight into the assembly and function of theMacB-powered TEP
(Table 1, Figure 3).
The Outer Membrane Exit Duct, TolC
The first structural component of a TEP solved was the TolC
outer membrane channel (Koronakis et al., 2000; Figure 3).
Three TolC monomers trimerise to form a 12-stranded β-barrel
and a 100 Å long α-helical tunnel extending down into the
periplasm. An equatorial domain comprising the N- and C-
termini forms a belt around the middle of the α-helical domain.
This α-tunnel is composed of six pairs of coiled coils packing
together, and has an approximate diameter of 35 Å for almost
its entire length. At the bottom of the channel, three aspartate
residues, one from each monomer, form a constriction of ∼4Å
effectively closing the channel at the periplasmic side of the
membrane. This closed conformation of the tunnel is constrained
by an inter- and intra-monomer network of hydrogen bonds
and salt bridges. Crystal structures of TolC variants, in which
this stabilizing network was disrupted by one or more point
mutations, suggested how the duct opens to allow passage of
substrate (Bavro et al., 2008; Pei et al., 2011). Subsequently,
pseudoatomic cryo-EM structures of the AcrAB-TolC pump,
in the presence and absence of substrate, revealed the iris-
like opening of the periplasmic constriction of wild-type TolC
(Wang et al., 2017). TolC homologs from other organisms are
divergent in sequence and exhibit variation in the structure of
the equatorial domain (Akama et al., 2004; Federici et al., 2005;
Kulathila et al., 2011; Su et al., 2014; Guan et al., 2015; Yonehara
et al., 2016). However, the same β-barrel and α-tunnel structure is
evident suggesting the gross topology is likely to be conserved in
all outer membrane eﬄux channels fromGram-negative bacteria.
The Periplasmic Adaptor Protein, MacA
Structures of E. coli and Aggregatibacter actinomycetemcomitans
MacA have both been solved by X-ray crystallography (Yum
et al., 2009; Xu et al., 2012). Like the RND pump adaptors,
AcrA (Mikolosko et al., 2006) and MexA (Higgins et al., 2004),
the MacA adaptor comprises helical hairpin, lipoyl, β-barrel
and MP domains. The native MacA protein also has an N-
terminal TMH, which distinguishes it from other adaptors,
including AcrA and MexA, typically anchored to the inner
membrane by anN-terminal lipoyl group (Hinchliffe et al., 2013).
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TABLE 1 | Structures in the Protein Data Bank associated with MacAB-TolC.
Protein Organism PDB Details Resolution (Å) Publication
TolC E. coli 1EK9 Trimer, closed state. C-terminal 43 amino acids removed. 2.1 Koronakis et al., 2000
MacA A. actino 4DK0 Functions as a hexamer, TMH removed. 3.5 Xu et al., 2012
E. coli 3FPP Functions as a hexamer, TMH removed. MP present but not
resolved.
2.99 Yum et al., 2009
S. pneu 5XU0 SeMet, functions as a hexamer, MP domain and TMH removed. 2.95 Yang et al., 2018
MacB A. actino 5LIL ATPÈS-bound
dimer (P21).
3.35 Crow et al., 2017
5LJ6 ATP-bound dimer (P6522). 3.9 Crow et al., 2017
5LJ7 ATP-bound dimer (P21). 3.25 Crow et al., 2017
A. baumannii 5GKO SeMet labeled, nucleotide-free dimer. 3.39 Okada et al., 2017
5WS4 ADPβS-bound dimer. 3.4 Okada et al., 2017
S. pneu 5XU1 Nucleotide-free dimer. 3.3 Yang et al., 2018
MacAB-TolC E. coli 5NIL Nucleotide-free MacA6MacB2TolC3 assembly
Cryo-EM (MacB region).
5.3 Fitzpatrick et al., 2017
E. coli 5NIK Nucleotide-free MacA6MacB2TolC3 assembly.
Cryo-EM (MacA-TolC region). TolC in the open state.
3.3 Fitzpatrick et al., 2017
MacB periplasmic
domains
A. actino 3FTJ Monomer, functions as dimer in full-length protein. 2.0 Xu et al., 2009
E. coli 5C59 SeMet monomer
(P21 β = 99.7
◦).
Functions as a dimer in full-length protein.
3.0 Ha and Kim,
unpublished
E. coli 5LJ8 Monomer, extended conformation (P21 β = 92.9
◦).
Functions as a dimer in full-length protein.
1.95 Crow et al., 2017
MacB cytoplasmic
NBD
E. coli 5LJ9 Nucleotide-free monomer.
(C2221), functions as a dimer in full-length protein.
2.3 Crow et al., 2017
E. coli 5LJA Nucleotide-free monomer
(P6122), functions as a dimer in full-length protein.
2.4 Crow et al., 2017
A. actino, Aggregatibacter actinomycetemcomitans; S. pneu, Streptococcus pneumoniae; SeMet, selenomethionine labeled; MP, Membrane proximal; TMH, Transmembrane helix.
However, the MacA crystal structures were determined using
protein constructs lacking this N-terminal TMH. Both E. coli
and A. actinomycetemcomitans MacA crystallized as hexamers
without additional stabilization using chemical cross-linking
reagents or engineered disulfide bonds (Yum et al., 2009; Xu
et al., 2012). The MacA hexamer resembles an inverted funnel
with the 70 Å stem formed by the hairpin domains and a
wider mouth formed by association of the lipoyl and β-barrel
domains. The cryo-EM structure of E. coli MacA within the
context of the assembled pump revealed a similar hexameric
organization (Fitzpatrick et al., 2017). Notably, six lipoyl domain
loops, one from each monomer, project into the center of
the MacA channel. The resulting constriction is stabilized by
inter-protomer hydrogen bonds between glutamine residues at
the tip of the loop (Fitzpatrick et al., 2017). These glutamine
residues are conserved in MacA proteins (Yum et al., 2009;
Fitzpatrick et al., 2017) but replacement with alanine did not
affect MacAB conferred erythromycin resistance (Fitzpatrick
et al., 2017). Instead, steered molecular dynamics simulations
suggested that the lipoyl domain loops favor unidirectional
movement of erythromycin through the MacA channel. The
construction in the MacA hexamer could therefore act as a gate
to regulate flow of substrates through the assembled eﬄux pump
(Fitzpatrick et al., 2017).
The Inner Membrane ABC Transporter,
MacB
The structure of the isolated periplasmic domain of the
monomeric MacB periplasmic domain was solved almost 10
years ago revealing the presence of two subdomains (Xu et al.,
2009). However, without the context of the membrane, it was
difficult to infer details of the transport mechanism. Now, a series
of structures of full-length MacB have helped reveal molecular
details of its operation. MacB from A. actinomycetemcomitans
and A. baumannii were crystallized in ATP- and ADP-bound
forms, respectively (Crow et al., 2017; Okada et al., 2017;
Figure 3). MacB crystallized as a dimer consistent with analytical
ultracentrifugation and atomic force microscopy studies (Lin
et al., 2009). Each MacB monomer comprises an N-terminal
NBD, four TMHs and a large periplasmic domain between
TMH1 and TMH2. Helical extensions of TMH1 and TMH2
from each monomer form a four helix bundle that elevates
the periplasmic domain above the plane of the membrane,
giving a mushroom-like appearance. TMH3 and TMH4 pack
on the outside of the helical bundle and are linked by a
short extracytoplasmic loop which has been referred to as the
“shoulder” (Crow et al., 2017). The cytoplasmic N-terminus of
TM1 is connected to the NBDs by an amphipathic helix running
parallel to the membrane surface and a “skirting loop.” The
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FIGURE 3 | Key structures from the MacAB-TolC tripartite efflux pump.
Protein data bank accession codes are given in brackets and the reported
resolution indicated in blue text. The complete MacAB-TolC pump is a
cryo-EM structure with higher resolution in the MacA/TolC region and lower
resolution in MacB (Fitzpatrick et al., 2017).
major coupling helix is located on the cytoplasmic side of the
membrane between TM2 and TM3, and provides a means of
communicating conformational changes from the NBDs to the
TMDs, as suggested for other ABC transporters. A second helix
at the C-terminus, the minor coupling helix, also makes contact
with the NBD. Deletion of the minor coupling helix had a modest
impact on activity of E. coliMacB (Crow et al., 2017) but a greater
effect on A. baumannii MacB mediated macrolide resistance
(Okada et al., 2017), which may reflect differences in the assays
used.
The two subdomains of the MacB periplasmic domain are
the Porter, named for structural similarity to a domain of AcrB,
and the Sabre named for the acronym: Small, alpha/beta rich,
extracytoplasmic. The Sabre domain is formed from a contiguous
stretch of residues (347–465 in A. actinomycetemcomitansMacB)
while the Porter domain is formed from two β-α-β motifs found
on either side of the Sabre domain (residues 306–346 and 466–
503). The Porter domain is directly connected to both stalk
helices of the MacB monomer. The same fold is evident in the
ADP-bound A. baumannii MacB structure although there are
striking differences in conformation (see mechanotransmission
section below). The crystal structures reveal that the architecture
of MacB is clearly distinct from classic ABC exporters such
Sav1866 (Figure 4). Like other multidrug exporters, Sav1866 is
characterized by a 6-TMH topology, C-terminally fused NBD,
and a coupling helix located between TMH4 and TMH5 of each
monomer that reciprocally “cross-over” to engage the NBDs.
MacB, in contrast, has four TMHs, an N-terminally fused NBD, a
FIGURE 4 | Topological comparison of MacB (a Type VII ABC transporter) with
classical exporter Sav1866 (a Type IV ABC transporter). (A) Topology diagrams
based on structures of MacB and Sav1866. (B) Linear domain arrangements
for MacB (upper) and Sav1866 (lower). CH, Coupling Helix; NBD,
Nucleotide-Binding Domain. White boxes indicate transmembrane helix
numbering.
large periplasmic domain and amajor coupling helix that engages
the NBDs in intra-molecular fashion.
The Assembled MacAB-TolC Tripartite
Pump
The significant technical challenge of isolating an assembled
MacAB-TolC pump and maintaining it through the purification
procedure was achieved by creating a fusion of MacA to
the C-terminus of MacB, and subsequently by introducing
specific cysteine residues into MacA and MacB to stabilize their
interaction with disulfide bonds (Fitzpatrick et al., 2017). Crystal
structures of E. coli MacA (Yum et al., 2009), E. coli TolC
(Koronakis et al., 2000) were already available. Docking these,
and a homologymodel of E. coliMacB based on theA. baumannii
MacB structure (Okada et al., 2017), into a cryo-EMmap enabled
the structure of the E. coli MacAB-TolC assembly to be solved
(Fitzpatrick et al., 2017) (Figure 3). The assembled tripartite
pump comprises a single MacB dimer, MacA hexamer and the
trimeric TolC exit duct. The complete MacAB-TolC assembly
is approximately 320 Å long, comparable to the size of the
AcrAB-TolC pump (Du et al., 2014; Daury et al., 2016).
The structure reveals how the three components interact in
the context of an assembled pump (Fitzpatrick et al., 2017). The
tips of theMacA hairpin domains intermesh with the periplasmic
ends of the TolC coiled coils. These “tip to tip” interactions were
first suggested on the basis of in vitro binding experiments (Xu
et al., 2010), and EM analysis of a complex of E. coli MacA
and a hybrid protein bearing the tip regions of the TolC helical
barrel (Xu et al., 2011). Association with MacA stabilizes the
TolC trimer in an open state in which the aspartates at the
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periplasmic constriction are almost 30 Å apart. This results in a
continuous channel from the top of TolC down to the lipoyl loop
constriction in MacA. Adaptor interactions with the periplasmic
domain of MacB are mediated by the MacA β-barrel and MP
domains. The annulus of MacA β-barrel domains sit on top of
MacB with three MacA monomers contacting each MacB. The
ring of MacA MP domains makes extensive contacts with the
MacB periplasmic domain consistent with previous biochemical
studies (Modali and Zgurskaya, 2011). Two MacA MP domains
contact the Sabre, and one interacts with the Porter subdomain
of each MacB monomer. The MacA hairpin and lipoyl domains
do not contact MacB (Fitzpatrick et al., 2017).
The MacB structure within the assembled complex resembles
that of the ADP-bound A. baumannii structure. The NBDs are
separated and the MacB stalk helices bend away from each other
leading to a separation of the periplasmic domains and formation
of a periplasmically accessible cavity between MacB and MacA
(Fitzpatrick et al., 2017).
THE MECHANOTRANSMISSION
MECHANISM OF MacB
Canonical ABC transporters provide a transmembrane substrate
pathway in the form of a vestibule or cavity located between
the two halves of the dimer interface (Choudhury et al., 2014).
Analysis of the MacB structures described above indicate there
is not a sufficient channel to provide a transmembrane pathway
for substrate in either the ATP or nucleotide-free state (Crow
et al., 2017). Furthermore, a functional MacAB-TolC pump is
required to export peptide substrate enterotoxin STII (Yamanaka
et al., 2008; Crow et al., 2017). STII is exported to the periplasm
by the Sec system, and requires the action of the periplasmically
located Dsb system to catalyze the formation of its two disulfide
bonds (Foreman et al., 1995). Taken together, these data suggest
MacB does not transport substrates across the inner membrane
but instead accepts substrates in the periplasm and, in concert
with MacA, ejects them across the outer membrane via the TolC
exit duct (Figure 5). This mechanism is functionally akin to the
“periplasmic vacuum cleaner” model, proposed for RND-type
transport pumps, in which substrates are bound in the periplasm
and ejected across the outer membrane (Aires and Nikaido,
2005). The network is completed by standalone transporters
in the inner membrane which remove substrates from the
cytoplasm (Tal and Schuldiner, 2009).
How then do ATP-induced changes in the cytoplasmic NBDs
affect the periplasmic domains ofMacB? Comparison of the ATP-
bound and free forms of MacB reveal long-range conformational
changes in the transmembrane helices, stalk and periplasmic
domains (Crow et al., 2017; Fitzpatrick et al., 2017; Okada
et al., 2017). In the nucleotide-free form, ATP binding induces
dimerization of the NBDs causing the major coupling helix
to push upwards on TM2. The resultant “zipping up” of the
transmembrane helices into a rigid 4-helix bundle brings the
periplasmic domains of each monomer together, eliminating
the cavity between them (Figure 6). We term these long-range
movements mechanotransmission, as ATP hydrolysis is not used
to transport a substrate across the membrane in which the ABC
FIGURE 5 | Toxin secretion and antibiotic resistance by the MacAB-TolC
tripartite efflux pump. (Left) A model for enterotoxin STII secretion: (1)
Enterotoxin STII is produced ribosomally in the cytoplasm and transported to
the periplasm by the Sec machinery. (2) The N-terminal secretion signal (purple
bar) is cleaved and two disulfide bonds are incorporated by DsbA. (3) Export
of enterotoxin across the bacterial outer membrane is driven by the
MacAB-TolC pump. (Right) A model for antibiotic detoxification: (i) antibiotics
(here erythromycin) in the cytoplasm are directed to periplasm by inner
membrane pumps. (ii) Antibiotics in the periplasm are driven across the
bacterial outer membrane by MacAB-TolC. Adapted from Crow et al. (2017).
FIGURE 6 | Mechanotransmission mechanism of MacB. ATP binding and
hydrolysis cause large, transmembrane conformational changes in MacB
structure. Rather than transporting substrates across the inner membrane,
MacB-like proteins coordinate reversible dimerization of their NBDs with
periplasmic conformational changes. TEP-forming MacB homologs use
periplasmic conformational change to drive substrates across the bacterial
outer membrane via TolC-like exit ducts. MacB homologs that do not form
TEPs are proposed to use similar motions during lipoprotein trafficking and
transmembrane signaling. Adapted from Crow et al. (2017).
protein resides, but instead to transmit conformational changes
from cytoplasmic NBDs to achieve useful work in the periplasm.
The importance of the relative movements of the stalk helices was
underlined by a severe reduction in MacB function in vivo when
the helices were locked together with a disulfide bond (Crow
et al., 2017).
Docking of the ATP-bound MacB form into the cryo-EM
MacAB-TolC structure has led to the suggestion that MacB
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could harness mechanotransmission to operate the assembled
pump as a molecular bellows (Crow et al., 2017; Figure 7). The
MacA hexamer accommodates the MacB periplasmic domain in
both open (ATP-free) and closed (ATP-bound) conformations.
Initially, the pump is in a nucleotide-free state in which the
stalk helices and periplasmic domains of MacB are separated.
Consequently, substrates can enter the cavity at the interface of
MacB and MacA. ATP binding brings the NBDs together and the
mechanotransmission mechanism results in tight association of
the stalk helices and MacB periplasmic domains. The ensuing
reduction in the cavity volume creates pressure which forces
the substrates upwards into the MacA channel and through the
MacA gate described above. Once the pressure is equalized, the
gate closes, preventing backflow of substrates. ATP hydrolysis
then resets the pump, with the MacB stalk helices moving apart
allowing substrates to bind and another round of eﬄux to
proceed. The proposed model requires a mechanism to prevent
substrate egress back through MacB. Cryo-EM analysis of the
assembled AcrAB-TolC TEP revealed a∼10 Å contraction along
the long axis of the pump in the substrate-bound state (Wang
et al., 2017). A similar contraction of the MacAB-TolC TEP
could ensure that MacA packs more tightly around MacB to
ensure substrates are driven out through MacA/TolC rather than
escaping into the periplasm. Clearly, structures of a substrate-
bound state of the MacB-driven TEP will be invaluable in
determining the precise details of its mechanism.
FIGURE 7 | A molecular bellows mechanism for the MacAB-TolC pump driven
by mechanotransmission. The proposed catalytic cycle of the MacAB-TolC
efflux pump (Top) is shown in comparison with the operation of a fireplace
bellows (Bottom). Substrates are driven out by
mechanotransmission-induced changes in the MacB periplasmic domains and
prevented from flowing back into the periplasm by a valve in MacA. The
individual pump components are colored: MacB (red), MacA (purple), TolC
(green) and substrate (blue). Adapted from Crow et al. (2017).
Little is known about how substrates are recognized by MacB.
Unexplained electron density at the cleft between the MacB
periplamic domains in the assembled pump could represent an
endogenous substrate (Fitzpatrick et al., 2017), but details remain
obscure. Mutagenesis of a patch of predominantly hydrophobic
residues, on the interior surface of the periplasmic domain,
reduced MacB conferred resistance to erythromycin, bacitracin
and colistin. This patch constitutes a plausible substrate binding
domain (Crow et al., 2017). However, it is still unclear whether
antibiotics are directly eﬄuxed or resistance is mediated as an
indirect effect of transport of another substrate. Zgurkskaya
and colleagues demonstrated E. coli MacA co-purified with
lipopolysaccharide and suggested the native substrate could be
a glycolipid (Lu and Zgurskaya, 2013).
Biochemical data suggests that MacA is able to influence the
ATPase activity of MacB and may have a role in communicating
the presence or absence of substrate in the periplasm to
the cytoplasmic NBDs (Tikhonova et al., 2007; Modali and
Zgurskaya, 2011; Lu and Zgurskaya, 2012). Deletion of the
cytoplasmic region, or N-terminal MacA TMH, compromised
the MacA-mediated stimulation of MacB ATPase activity in vitro
and prevented MacAB mediated macrolide resistance in vivo
(Tikhonova et al., 2007). The structural basis for ATPase
stimulation remains unclear, because the MacA TMH was not
resolved in the MacAB-TolC cryo-EM structure (Fitzpatrick
et al., 2017).
MacB FAMILY MEDIATED ANTIBIOTIC
RESISTANCE IN GRAM-POSITIVE
BACTERIA
The classic view of adaptor proteins is that they serve to
bridge the inner and outer membrane components of TEPs.
Bioinformatic analysis suggesting the widespread presence
of adaptor proteins in Gram-positive bacteria was therefore
somewhat unanticipated (Harley et al., 2000; Zgurskaya et al.,
2009). Many of the genes encoding these Gram-positive adaptor
proteins are found in operons with homologs of macB. The first
of these systems to be characterized, YknXYZ, is responsible
for protection from the endogenous toxin, sporulation delaying
peptide (SDP). The release of SDP causes lysis of nearby cells to
provide nutrients for producing cells to complete sporulation – a
process that has been described as bacterial cannibalism. Mature
SDP is a 42 amino acid peptide with one disulfide bond (Liu
et al., 2010). Structures of the adaptor protein YknX (Xu et al.,
2017) reveal that it has the same fold and hexameric arrangement
as E. coli MacA (Yum et al., 2009; Fitzpatrick et al., 2017).
Similarly, the permease component YknZ is clearly homologous
to the transmembrane and periplasmic domain of MacB (Xu
et al., 2016; Fitzpatrick et al., 2017), while YknY encodes a
cytoplasmic NBD. Sec-dependence of SDP export suggests that
like MacB, YknXYZ probably mediates its protective effect from
the extracytoplasmic side of the membrane—perhaps by keeping
SDP away from the bilayer. Interestingly, a co-transcribed
membrane protein, YknW, may influence the oligomerisation
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and/or conformational state of the adaptor YknX, but its role
remains enigmatic (Yamada et al., 2012).
In Enterococcus faecalis, a MacB-type transporter and cognate
adaptor are required for protection against endogenously
produced AS-48, a 70 amino acid cyclic peptide antibiotic
(González et al., 2000). A 10 gene cluster organized into two
operons is associated with AS-48 biosynthesis. The first operon
encodes genes responsible for AS-48 production and export
across the cytoplasmic membrane while the second operon, AS-
48EFGH, is important for resistance to exogenous AS-48 (Diaz
et al., 2003). Together, AS-48G (NBD) and AS-48H (TMD)
encode a MacB-like ABC transporter with an extracytoplasmic
domain of approximately 230 amino acids. AS-48E is predicted to
contain four TMHs and cytoplasmic N- and C-termini. Further
investigation is required to establish the role of AS-48E and
whether it influences the AS48-FGH pump activity in a similar
manner to YknW in the SDP-exporting pump described above.
A global analysis of Streptococcus pneumoniae D39 gene
expression showed upregulation of an operon (Sp0785-0787) in
response to bacitracin and the human defensin LL-37. Deletion
of this operon increased susceptibility to LL-37 and lincomycin
(Majchrzykiewicz et al., 2010). Analysis of these genes suggest
they encode a periplasmic adaptor protein and transporter
homologous to MacB. Very recently, structures of the equivalent
proteins from S. pneumoniae R6 (Spr0693-0695) were obtained
(Yang et al., 2018). These structures reveal remarkable structural
similarity to the Gram-negative proteins already crystallized. S.
pneumoniae MacA (hereafter SpMacA) was crystallized in the
absence of the MP domain and is made up of characteristic β-
barrel, lipoyl and α-helical hairpin domains. A lipoyl domain
loop from each monomer projects into the SpMacA channel
in a similar fashion observed in the E. coli MacA structure
(Fitzpatrick et al., 2017). However, the residue at the tip is not
conserved and the physiological role of the SpMacA loop was not
tested (Yang et al., 2018). SpMacB is remarkably similar to the
Gram-negative MacB structures (Crow et al., 2017; Fitzpatrick
et al., 2017; Okada et al., 2017; Yang et al., 2018). It was
crystallized in the presence of the non-hydrolysable ATP analog
AMP-PNP although this was not resolved in the structure, and
the arrangement of the stalk helices is more similar to the ADP-
bound or nucleotide-free form (Fitzpatrick et al., 2017; Okada
et al., 2017; Yang et al., 2018). As with E. coliMacAB (Tikhonova
et al., 2007), the ATPase activity of SpMacB reconstituted in
proteoliposomes was stimulated by co-reconstitution with full-
length SpMacA, but not by variants lacking the cytoplasmic
region and N-terminal TMH (Yang et al., 2018).
In these Gram-positive systems, an adaptor protein is present
but in the absence of an outer membrane, what is its role? Cryo-
EM studies of vitrified cell samples reveal a discrete zone between
the inner membrane and peptidoglycan akin to a Gram-positive
“periplasm” (Matias and Beveridge, 2006; Zuber et al., 2006).
The presence of these adaptors could therefore form channels to
remove xenobiotics from this space, and prevent their immediate
re-association with the membrane. The height of the SpMacA
channel is consistent with the dimensions of this periplasm-like
zone (Yang et al., 2018) and purified YknX adaptor is able to bind
peptidoglycan (Xu et al., 2017). Further analysis of Gram-positive
MacAB-like assemblies is vital to understand their roles
in vivo.
SENSING AND RESISTING THE THREAT
OF LANTIBIOTICS USING THE MacB
ARCHITECTURE
Lantibiotics are post-translationally modified peptides
containing the polycyclic thioether amino acids lanthionine
or methyllanthionine e.g., bacitracin and nisin (Draper et al.,
2015). They are produced by low G+C Gram-positive bacteria
and typically interfere with cell wall/peptidoglycan biosynthesis
by binding to precursors such as undecaprenyl-pyrophosphate
(UPP) and Lipid II (Draper et al., 2015). Multiple methods
of resistance to lantibiotics exist, but intriguingly one class of
resistance proteins are ABC transporters homologous to MacB
proteins. These systems are exemplified by BceAB of B. subtilis
but multiple homologs in other Gram-positive bacteria have
been characterized including Streptococcus mutans MbrAB
(Tsuda et al., 2002), Listeria monocytogenes AnrAB (Collins et al.,
2010), S. aureus VraFG (Meehl et al., 2007), and Streptococcus
agalactiae NsrFP (Khosa et al., 2013).
BceA encodes an ATPase domain, while BceB is a membrane
permease with ten TMHs and a large extracellular domain
between TMH7 and TMH8. The final four TMHs and
intervening periplasmic domain are topologically similar to
MacB. Intriguingly, the BceAB-type transporters appear to have
coevolved with a two-component system (TCS) that works with
BceAB to sense and respond to extracellular antibiotics (Coumes-
Florens et al., 2011; Dintner et al., 2011). Typically, TCSs consist
of a membrane intrinsic histidine kinase that phosphorylates a
response regulator to control gene expression in response to an
external stimulus. Two-hybrid analysis of the proteins suggest
that BceB and BceS directly interact (Kallenberg et al., 2013;
Dintner et al., 2014). However, unlike in classical TCS systems,
the histidine kinase (BceS) cannot directly sense antibiotics
and requires the presence of BceB and an active BceA ATPase
domain to respond to bacitracin (Rietkötter et al., 2008). Two
different mechanisms for BceB mediated detoxification have
been suggested. Kingston and colleagues proposed that BceAB
induces resistance by flipping UPP into the inner leaflet of the
cytoplasmic membrane, thereby protecting it from bacitracin
(Kingston et al., 2014). Conversely, Dintner and coworkers
demonstrated purified BceAB complex could directly bind
bacitracin-Zn2+, the active form of the peptide, with nanomolar
affinity. They therefore suggested that BceABmediates resistance
by direct eﬄux of bacitracin itself (Dintner et al., 2014). Though
the nature of the substrate in vivo remains unclear, BceAB is
active in both the sensing and detoxification of bacitracin.
Analysis of the BceB sequence suggests a possible fusion of
two MacB architectures in which the first periplasmic domain
has been lost (Dintner et al., 2014). Consistent with this
idea, bacterial two-hybrid analysis suggests BceB monomers
do not interact. Furthermore, size-exclusion chromatography
analysis of detergent-purified BceA:BceB complex suggested
a 2:1 stoichiometry, although the purified complex did not
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have ATPase activity (Dintner et al., 2014). Mutations affecting
both sensing, and detoxification, of bacitracin map to the C-
terminal half of BceB, including TMH8 (Kallenberg et al.,
2013). This helix is equivalent to TMH2 in MacB, suggesting a
mechanotransmission-like mechanism could also underpin BceB
action.
Unlike YknYZ and SpMacB discussed in the previous section,
BceAB is not associated with an adaptor protein. However,
interestingly, the activity of a BceAB homolog from S. aureus
(VraDE) is modulated by a two-TMHmembrane protein (VraH)
that has cytoplasmic N- and C-termini. Two-hybrid analysis
demonstrated VraH interacts with VraE and increases resistance
to daptomycin and gallidermin but the mechanism of this
modulation is not clear (Popella et al., 2016).
INSIGHTS INTO THE WIDER MacB FAMILY
OF ABC TRANSPORTERS
TEP-Forming MacB Homologs
The structures and mechanisms detailed here are also likely to
apply to MacB homologs operating as part of tripartite eﬄux
pumps to export substrates other than antibiotics (Table 2).
One such example is export of the siderophore pyoverdine by
Pseudomonas aeruginosa PvdRT-OpmQ. Pyoverdine is matured
by periplasmic enzymes, and mutants lacking PvdRT accumulate
pyoverdine in the periplasm. These observations suggest that the
MacB homolog PvdTmediates transport from the periplasm, not
the cytoplasm (Hannauer et al., 2010). In other Pseudomonas
species, homologs of MacAB are required for phytotoxin
secretion (Cho and Kang, 2012). In these systems, the toxin
biosynthetic operons include homologs of MacAB. By analogy
with MacB, another pump would be required to export the
non-ribosomally synthesized peptide across the cytoplasmic
membrane into the periplasm, a role which could be fulfilled by
SyrD-type ABC transporters (Quigley et al., 1993).
The MacB-type ABC transporter DevCA, adaptor protein
DevB and TolC homolog HgD form a TEP responsible for
glycolipid export underpinning heterocyst formation in the
nitrogen fixating cyanobacterium Anabaena. Deletion of the N-
terminus of DevB prevents substrate export, but not association
with DevCA, suggesting the cytoplasmic region of the adaptor
protein can control the activity of the pump as proposed for
E. coliMacAB-TolC (Staron et al., 2011, 2014).
Enteroaggregative E. coli express a virulence plasmid-encoded
MacB based TEP dedicated to the export of dispersin, a
positively-charged, surface-associated protein, that prevents
bacterial aggregation (Nishi et al., 2003). A similar TEP exports
the dispersin homolog, CexE, from enterotoxigenic E. coli
(Pilonieta et al., 2007). The structure of 10 kDa dispersin is made
up of two antiparallel 3-stranded beta-sheets with decorating α-
helices at either end, resulting in a 20 Å diameter, 50 Å long
“bullet” shape (Velarde et al., 2007). The narrowest dimension
is consistent with transport through the periplasmic cavity of
MacB (and the lumen of the TolC exit duct) but may represent
the upper size-bound for folded substrates that are transported
by MacB-dependent TEPs.
TEP-Independent MacB Homologs
The MacB architecture is also found in proteins that operate
independently of adaptor proteins/TEPs (Table 3). For example,
LolCDE, an ABC transporter with the same topological
organization asMacB, underpins lipoprotein trafficking in Gram-
negative bacteria. Lipoproteins destined for the outer membrane
are first transported across the cytoplasmic membrane by
the Sec system, and then successively acylated by membrane
intrinsic machineries (Narita and Tokuda, 2017). LolCDE then
extracts the lipid moiety of lipoproteins from the outer leaflet
of the inner membrane and passes it to the periplasmic
chaperone LolA for delivery to the outer membrane. LolD
encodes an NBD, while LolC and LolE both have the 4-TM
helix MacB type architecture (Yakushi et al., 2000; Narita and
Tokuda, 2017). The structure of the periplasmic domain of
LolC revealed a fold homologous to MacB, suggesting that
lipoprotein extraction could be performed by the LolCDE
complex using a mechanotransmission mechanism (Crow et al.,
2017).
The MacB architecture is also found in FtsEX which is
required for efficient cell division in Gram-negative bacteria
(Schmidt et al., 2004; Yang et al., 2011; Du et al., 2016),
sporulation in Bacillus (Garti-Levi et al., 2008) and survival
of mycobacteria (Mavrici et al., 2014) and Streptococcus (Sham
et al., 2011). In these organisms, the FtsEX complex is proposed
to regulate the activity of extracytoplasmic cell wall amidases
in the final stages of cell division. The periplasmic domain
of Mycobacterium tuberculosis FtsX lacks a significant Sabre
subdomain, but the Porter subdomain is remarkably similar
to that of E. coli MacB (Mavrici et al., 2014; Crow et al.,
2017). The absence of the Sabre and conservation of the Porter
subdomain in FtsEX raises interesting questions regarding the
role of these subdomains in MacB and other Type VII ABC
transporters, including LolCDE and FtsEX. As far as we are
aware, the Porter subdomain is present in all members of
the Type VII ABC superfamily and is likely an intrinsic part
of the mechanotransmission apparatus. The role of the Sabre
subdomain is less obvious but it may be adapted to carry out
specific tasks in different proteins.
HrtAB is another ABC transporter homologous to MacB
found throughout Gram-positive bacteria. The HrtAB pair were
initially proposed to protect cells from the toxic effect of high
concentrations of heme by removing it from the cytoplasm
(Stauff et al., 2008; Bibb and Schmitt, 2010). Direct transfer of
substrates from the cytoplasm to the extracellular space has not
yet been demonstrated, and more recent studies suggest HrtAB
removes heme from the membrane in S. aureus (Wakeman
et al., 2012) and L. lactis (Joubert et al., 2014). Consistent
with this idea, mutation of two conserved tyrosine residues in
the periplasmic domain abrogated HrtAB mediated tolerance
of heme stress. Comparison of HrtB with MacB suggests these
residues map to the top of the stalk, and so it is tempting to
speculate that they could co-ordinate heme during transport.
Further study of HrtAB is essential to assess whether this
assembly receives substrates from the cytoplasm or not, and
whether it can transport such substrates across the inner
membrane.
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TABLE 2 | Representative MacB superfamily TEPs.
Protein Organism(s) Complex Substrate(s) Function(s) References
MacB Gram-negative
bacteria
MacAB-TolC (TEP) Enterotoxin STII, Erythromycin,
Colistin, Bacitracin, Kanamycin,
Glycolipids, Protoporphyrin
Toxin secretion
Antibiotic resistance
Cell envelope biogenesis?
Detoxification?
Kobayashi et al., 2001;
Yamanaka et al., 2008; Lu and
Zgurskaya, 2013; Turlin et al.,
2014; Crow et al., 2017
PvdT Pseudomonas
aeruginosa
PvdRT-OpmQ (TEP) Pyoverdine Siderophore export
Virulence?
Imperi et al., 2009; Hannauer
et al., 2012
AatP Enteroaggregative
E. coli (EAEC)
AatABCP (TEP) Dispersin Biofilm dispersal signaling Nishi et al., 2003; Velarde et al.,
2007
DevC Anabaena sp. DevABC-TolC Glycolipids Heterocyst envelope biogenesis Staron et al., 2011, 2014
CexP Enterotoxigenic
E. coli (ETEC)
CexPABC CexE? CexE secretion? Pilonieta et al., 2007
TABLE 3 | Representative non-TEP forming homologs of the MacB ABC transporter.
Protein Organism(s) Complex Substrate(s) Function(s) References
LolC,
LolE,
LolF
Gram-negative bacteria LolCDE or LolDF Lipoproteins Lipoprotein extraction and
trafficking
Yakushi et al., 2000; Narita and
Tokuda, 2017
FtsX Gram-positive and
Gram-negative bacteria
FtsEX – Cell division Yang et al., 2011; Mavrici et al., 2014;
Du et al., 2016
YknZ Bacillus amyloliquefaciens YknXYZ Antimicrobial peptide? Detoxification? Yamada et al., 2012; Xu et al., 2017
BceB Bacillus subtilis BceABS Bacitracin, Sensing & detoxification Dintner et al., 2014
HrtB Gram-positives HrtAB Heme? Detoxification? Stauff et al., 2008; Bibb and Schmitt,
2010
AS-48H Enterococcus faecalis AS-48EFGH Mature AS-48? Bacteriocin AS-48 export? Diaz et al., 2003
YbbP is an E. coli protein of unknown function that appears
to represent a fusion of two MacB permease units with two
linking TMHs. Surveying this, and other homologs, reveals that
the MacB 4-TMH architecture may be organized in different
ways. The NBDs may be fused to the TMDs or encoded in
a separate polypeptide. Similarly, the transmembrane domains
may organize as homodimer (MacB and FtsX) or heterodimer
of individual units (LolCE). Alternatively, the two permease
domains may be fused into a single polypeptide with two
interceding TMHs, and either one (BceB) or two periplasmic
domains (YbbP; Figure 8). As previously noted by Milton
Saier, one permutation that appears to be absent in this ABC
superfamily is the fusion of two permease domains and two
NBDs into a single polypeptide (Khwaja et al., 2005). In cases
where the TMDs represent an apparent fusion of two monomers,
the NBD is always encoded as a separate protein (Khwaja et al.,
2005).
CONCLUSIONS AND FUTURE
DIRECTIONS
MacB and its homologs confer resistance to antibiotics, but
the current evidence suggests they do not transport substrates
across the cytoplasmic membrane. Crystal and cryo-EM
structures demonstrate how the distinctive MacB architecture
uses a mechanotransmission mechanism in which the energy
from cytoplasmic ATP hydrolysis is communicated through
transmembrane movements to perform useful work in the
extracytoplasmic space. Despite recent advances, many questions
remain. The absence of a substrate-bound structure is one of
the biggest barriers to our collective understanding of MacB-
type ABC transporters. Substrate-bound structures of other
ABC exporters are the exception, not the rule (Johnson and
Chen, 2017; Mi et al., 2017), but they would demonstrate how
substrate is recognized by the MacB periplasmic domain. The N-
terminus of MacA affects the ATPase activity of MacB but this
region has not been resolved in any of the current structures;
clearly structural information demonstrating how this region of
MacA can affect MacB is vital to completely understand the
mechanism.
All the available structures have been determined using
detergent-solubilised proteins but the presence of a membrane
environment dramatically alters the ATPase activity of MacB
and its response to MacA (Tikhonova et al., 2007; Picard et al.,
2018). Mass spectrometry analysis of purified MacB suggested it
specifically binds phosphatidylethanolamine molecules (Barrera
et al., 2009) while different phospholipids were found to
differentially affect the activity of the MacB homolog LolCDE
(Miyamoto and Tokuda, 2007). Structures of MacB within
the context of a lipid bilayer may help reveal how specific
phospholipids can modulate transporter activity.
Another important line of enquiry will be to better understand
the range of substrates that MacB-like proteins interact
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FIGURE 8 | Topological organization of MacB family members. Linear domain arrangement (Left) and transmembrane topologies (Right) are shown for MacB and
four representative homologs. From top to bottom, macrolide and toxin transporter MacB, cell division protein FtsEX, lipoprotein trafficking LolCDE, YbbAP (unknown
function), bacitracin sensing and efflux protein BceAB. MacB type ABC transporters share a distinctive transmembrane topology although NBDs are not always fused
to transmembrane encoding domain and some families exist as apparent fusions of two half-transporters. Sequence identity between the periplasmic domains of
each Type VII motif is low, but the extracellular domain of Mycobacterium tuberculosis FtsEX (Mavrici et al., 2014) also contains a Porter subdomain suggesting this
could be a common element of Type VII ABC proteins.
with. The peptide substrates of MacB and its homologs are
commonly small disulfide bonded peptides reminiscent of
some antimicrobial peptides such as mammalian defensins.
Expression of MacB-like proteins influences survival of
Salmonella and Streptococcus pyogenes in macrophages (Phelps
and Neely, 2007; Bogomolnaya et al., 2013). Whether MacB
can protect pathogenic bacteria within host systems by eﬄux
of defensins or other substrates bears further investigation.
Moreover, the sheer structural diversity and size-range of
the MacB substrate repertoire (ranging from ∼0.5 kDa
macrolides to 10 kDa proteins such as dispersin) requires
explanation.
In Bacillus, an additional membrane protein that is not
found in conventional tripartite systems from Gram-negative
bacteria, YknW, associates with and affects the activity of the
Gram-positive MacAB homolog YknXYZ. Furthermore, a small
membrane protein, AcrZ, modulates the action of the E. coli
AcrAB-TolC TEP (Hobbs et al., 2012). Many small membrane
proteins in E. coli remain uncharacterized (Storz et al., 2014), and
so the possibility of other proteins affecting the activity of MacB
cannot be excluded.
MacB mediated antibiotic resistance, and the involvement
of its homologs in different facets of bacterial physiology
make Type VII ABC transporters an attractive target for
antibiotic therapy. Inhibitors of MacAB have not been isolated,
but screening of chemical libraries identified two different
inhibitors that target the MacB homolog LolCDE (McLeod
et al., 2015; Nayar et al., 2015; Nickerson et al., 2018).
Mutations conferring resistance map to the stalk helices,
and interestingly, one of these inhibitors stimulated the
ATPase activity of LolCDE in vitro (Nickerson et al., 2018).
These inhibitors may therefore function by uncoupling ATP
Frontiers in Microbiology | www.frontiersin.org 12 May 2018 | Volume 9 | Article 950
Greene et al. MacB Superfamily Mediated Antibiotic Resistance
hydrolysis from the mechanotransmissive movement of the
extracytoplasmic domains. Clearly, a general class of inhibitors
that could interrupt mechanotransmission would be immediately
useful as tools to study MacB-like transporters and, in the
longer term, as potential new antibiotics. Indeed, targeting
MacB-like ABC transporters for inhibition is particularly
attractive, not only because FtsEX and LolCDE are essential,
but also because this class of transporters is absent in
humans.
The importance of the MacB architecture in bacterial
physiology is becoming increasingly apparent. The recent
structures now provide a template to understand its action not
only in antibiotic resistance but in underpinning a variety of
fundamental bacterial cell processes which are themselves targets
for antimicrobial therapy.
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